 Duc Ha
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Survivors | 9 | 2025 | 347 | 4.410 |
Why?
| | Lung Neoplasms | 18 | 2025 | 2679 | 3.880 |
Why?
| | Quality of Life | 10 | 2025 | 3246 | 1.540 |
Why?
| | Heart Rate | 3 | 2019 | 860 | 1.100 |
Why?
| | Survivorship | 2 | 2025 | 59 | 0.980 |
Why?
| | Dyspnea | 3 | 2023 | 252 | 0.860 |
Why?
| | Exercise Test | 5 | 2020 | 636 | 0.830 |
Why?
| | Telerehabilitation | 1 | 2023 | 50 | 0.730 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2025 | 198 | 0.710 |
Why?
| | Exercise | 5 | 2021 | 2219 | 0.690 |
Why?
| | Leisure Activities | 1 | 2021 | 31 | 0.660 |
Why?
| | Exercise Tolerance | 2 | 2020 | 289 | 0.650 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 1195 | 0.580 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 653 | 0.490 |
Why?
| | Chemoradiotherapy | 1 | 2018 | 239 | 0.490 |
Why?
| | Pneumonectomy | 2 | 2016 | 167 | 0.480 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 928 | 0.480 |
Why?
| | Lung | 4 | 2023 | 4141 | 0.460 |
Why?
| | Exercise Therapy | 1 | 2020 | 489 | 0.430 |
Why?
| | Respiratory Tract Diseases | 1 | 2015 | 178 | 0.400 |
Why?
| | Telemedicine | 1 | 2023 | 978 | 0.400 |
Why?
| | Neoplasms, Second Primary | 1 | 2015 | 103 | 0.400 |
Why?
| | Electromagnetic Phenomena | 1 | 2013 | 24 | 0.380 |
Why?
| | Forecasting | 1 | 2015 | 391 | 0.380 |
Why?
| | Fatigue | 3 | 2025 | 367 | 0.350 |
Why?
| | Bronchoscopy | 1 | 2013 | 228 | 0.340 |
Why?
| | Cross-Sectional Studies | 5 | 2021 | 6011 | 0.340 |
Why?
| | Heart Diseases | 1 | 2014 | 341 | 0.340 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2013 | 125 | 0.330 |
Why?
| | Neoplasm Staging | 3 | 2021 | 1492 | 0.330 |
Why?
| | Aged | 10 | 2021 | 26514 | 0.330 |
Why?
| | Neoplasms | 2 | 2025 | 2946 | 0.320 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 6164 | 0.320 |
Why?
| | Veterans | 2 | 2020 | 1675 | 0.310 |
Why?
| | Humans | 24 | 2026 | 147293 | 0.310 |
Why?
| | Lung Diseases | 1 | 2014 | 787 | 0.260 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 648 | 0.260 |
Why?
| | Adenocarcinoma | 1 | 2013 | 928 | 0.220 |
Why?
| | Lung Diseases, Interstitial | 2 | 2026 | 675 | 0.220 |
Why?
| | Patient Reported Outcome Measures | 2 | 2020 | 506 | 0.210 |
Why?
| | Complementary Therapies | 1 | 2025 | 96 | 0.210 |
Why?
| | Male | 11 | 2021 | 73950 | 0.200 |
Why?
| | Middle Aged | 7 | 2021 | 36821 | 0.190 |
Why?
| | Female | 11 | 2021 | 80076 | 0.190 |
Why?
| | Logistic Models | 2 | 2021 | 2142 | 0.190 |
Why?
| | Oxygen Consumption | 2 | 2016 | 721 | 0.190 |
Why?
| | Survivors | 2 | 2023 | 528 | 0.190 |
Why?
| | Muscles | 1 | 2023 | 330 | 0.180 |
Why?
| | Prognosis | 3 | 2016 | 4383 | 0.180 |
Why?
| | Retrospective Studies | 5 | 2021 | 17560 | 0.170 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 58 | 0.160 |
Why?
| | Confidence Intervals | 1 | 2021 | 330 | 0.160 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 126 | 0.150 |
Why?
| | Markov Chains | 1 | 2020 | 132 | 0.150 |
Why?
| | Autonomic Nervous System | 1 | 2019 | 83 | 0.140 |
Why?
| | Sleep Wake Disorders | 1 | 2023 | 315 | 0.140 |
Why?
| | Walking | 1 | 2023 | 549 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1776 | 0.140 |
Why?
| | California | 1 | 2020 | 477 | 0.140 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 545 | 0.130 |
Why?
| | Geriatric Assessment | 1 | 2020 | 240 | 0.130 |
Why?
| | Physical Fitness | 1 | 2019 | 209 | 0.130 |
Why?
| | Psychometrics | 1 | 2022 | 739 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1344 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1912 | 0.130 |
Why?
| | Life Style | 1 | 2020 | 504 | 0.130 |
Why?
| | Time Factors | 2 | 2021 | 7173 | 0.120 |
Why?
| | Disease-Free Survival | 1 | 2018 | 779 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1342 | 0.120 |
Why?
| | Self Report | 1 | 2021 | 887 | 0.120 |
Why?
| | Physical Education and Training | 1 | 2016 | 70 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2018 | 258 | 0.110 |
Why?
| | Parasympathetic Nervous System | 1 | 2015 | 26 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2025 | 11947 | 0.110 |
Why?
| | Risk Assessment | 2 | 2016 | 3784 | 0.110 |
Why?
| | Perioperative Period | 1 | 2015 | 71 | 0.110 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2015 | 38 | 0.110 |
Why?
| | Health Status | 1 | 2021 | 839 | 0.110 |
Why?
| | Survival Analysis | 1 | 2018 | 1386 | 0.110 |
Why?
| | Ohio | 1 | 2015 | 146 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2015 | 158 | 0.100 |
Why?
| | Mental Health | 1 | 2021 | 813 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3448 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 528 | 0.100 |
Why?
| | Risk Factors | 2 | 2021 | 11017 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 975 | 0.090 |
Why?
| | Translocation, Genetic | 1 | 2013 | 126 | 0.090 |
Why?
| | Odds Ratio | 1 | 2014 | 1084 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 1 | 2013 | 197 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1550 | 0.080 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 231 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 724 | 0.080 |
Why?
| | Survival Rate | 1 | 2015 | 2110 | 0.080 |
Why?
| | Multigene Family | 2 | 2008 | 210 | 0.070 |
Why?
| | ErbB Receptors | 1 | 2013 | 638 | 0.070 |
Why?
| | Chronic Disease | 1 | 2015 | 1844 | 0.070 |
Why?
| | Codon, Initiator | 1 | 2009 | 11 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 2133 | 0.070 |
Why?
| | Cohort Studies | 1 | 2020 | 6099 | 0.070 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 41 | 0.070 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2008 | 28 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 387 | 0.060 |
Why?
| | United States | 2 | 2026 | 16313 | 0.060 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 124 | 0.060 |
Why?
| | Prospective Studies | 1 | 2020 | 8164 | 0.060 |
Why?
| | Antigens, Neoplasm | 1 | 2008 | 273 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 445 | 0.060 |
Why?
| | Actins | 1 | 2006 | 428 | 0.050 |
Why?
| | Genome, Human | 1 | 2006 | 426 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 669 | 0.050 |
Why?
| | Genetic Testing | 1 | 2026 | 493 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2218 | 0.050 |
Why?
| | Lung Transplantation | 1 | 2026 | 338 | 0.050 |
Why?
| | Biopsy | 1 | 2026 | 1093 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2006 | 502 | 0.050 |
Why?
| | Societies, Medical | 1 | 2026 | 914 | 0.040 |
Why?
| | Proteins | 1 | 2006 | 1024 | 0.040 |
Why?
| | Adult | 2 | 2015 | 41405 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8430 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2026 | 886 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2009 | 398 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2026 | 2791 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2886 | 0.020 |
Why?
| | Infant | 1 | 2026 | 10194 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3565 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2009 | 32 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 143 | 0.020 |
Why?
| | Testis | 1 | 2008 | 165 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 539 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 512 | 0.020 |
Why?
| | Haplorhini | 1 | 2006 | 52 | 0.020 |
Why?
| | Azacitidine | 1 | 2008 | 168 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2006 | 69 | 0.020 |
Why?
| | Retroelements | 1 | 2006 | 50 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2006 | 335 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2006 | 362 | 0.010 |
Why?
| | Cell Lineage | 1 | 2008 | 381 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2134 | 0.010 |
Why?
| | Fetus | 1 | 2008 | 805 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2175 | 0.010 |
Why?
| | Gene Expression | 1 | 2008 | 1481 | 0.010 |
Why?
| | DNA Methylation | 1 | 2008 | 722 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 924 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1456 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2812 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4169 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 2054 | 0.010 |
Why?
| | Brain | 1 | 2008 | 3009 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2006 | 2420 | 0.010 |
Why?
| | Animals | 1 | 2006 | 38410 | 0.000 |
Why?
|
|
Ha's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|